FATE

FATE THERAPEUTICS INC

SEC CIK 1434316
$2.06 +79.1% · 90 days
90-day buys
$0
0 open-market
90-day sells
$102.6K
2 open-market
Net insider flow
−$102.6K
Net selling
Filings shown
67
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at FATE have sold a net $102.6K of stock (0 open-market buys vs 2 sells).

Largest recent trade: Valamehr Bahram sold $1.46M of FATE, trimming their stake 14%.

Most active filer: Valamehr Bahram, with 55 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for FATE, newest first
View on SEC EDGAR ↗
FATE
Sell TAHL CINDY · See Remarks · Open-market sale · filed 3w ago ΔOwn −3.9%

Tahl Cindy sold $48.1K of FATE, trimming their stake 4%.

−$48.1K
25,590 sh @ $2
FATE
Sell Valamehr Bahram · Director, President and CEO · Open-market sale · filed 3w ago ΔOwn −4.4%

Valamehr Bahram sold $54.5K of FATE, trimming their stake 4%.

−$54.5K
28,946 sh @ $2
Advertisement
FATE
Sell TAHL CINDY · See Remarks · Open-market sale · filed Jan 12, 2026 ΔOwn −2.7%

Tahl Cindy sold $11.3K of FATE, trimming their stake 3%.

−$11.3K
10,589 sh @ $1
FATE
Sell Valamehr Bahram · Director, President and CEO · Open-market sale · filed Jan 12, 2026 ΔOwn −1.5%

Valamehr Bahram sold $5.6K of FATE, trimming their stake 2%.

−$5.6K
5,190 sh @ $1
FATE
Sell TAHL CINDY · See Remarks · Open-market sale · filed Aug 5, 2025 ΔOwn −2.2%

Tahl Cindy sold $9.6K of FATE, trimming their stake 2%.

−$9.6K
9,037 sh @ $1
FATE
Sell Valamehr Bahram · Director, President and CEO · Open-market sale · filed Aug 5, 2025 ΔOwn −4.1%

Valamehr Bahram sold $15.4K of FATE, trimming their stake 4%.

−$15.4K
14,466 sh @ $1
FATE
Sell Valamehr Bahram · Director, President and CEO · Open-market sale · filed Jan 13, 2025 ΔOwn −2.4%

Valamehr Bahram sold $13.4K of FATE, trimming their stake 2%.

−$13.4K
8,705 sh @ $2
FATE
Sell Valamehr Bahram · Chief R&D Officer · Open-market sale · filed Jan 10, 2024 ΔOwn −6.7%

Valamehr Bahram sold $49.4K of FATE, trimming their stake 7%.

−$49.4K
11,271 sh @ $4
FATE
Sell Valamehr Bahram · Chief R&D Officer · Open-market sale · filed Jan 11, 2023 ΔOwn −6.1%

Valamehr Bahram sold $57.2K of FATE, trimming their stake 6%.

−$57.2K
10,917 sh @ $5
FATE
Sell Valamehr Bahram · Chief R&D Officer · Open-market sale · filed Jul 8, 2022 ΔOwn −8.7%

Valamehr Bahram sold $518.7K of FATE, trimming their stake 9%.

−$518.7K
17,158 sh @ $30
FATE
Sell Valamehr Bahram · Chief R&D Officer · Open-market sale · filed Jul 7, 2022 ΔOwn −4.2%

Valamehr Bahram sold $235.8K of FATE, trimming their stake 4%.

−$235.8K
7,842 sh @ $30
FATE
Sell COUGHLIN TIMOTHY · Director · Open-market sale · filed Jun 6, 2022 ΔOwn −2.4%

Coughlin Timothy sold $32.8K of FATE, trimming their stake 2%.

−$32.8K
1,439 sh @ $23
FATE
Sell Valamehr Bahram · Chief R&D Officer · Open-market sale · filed Mar 15, 2022 ΔOwn −8.1%

Valamehr Bahram sold $506.3K of FATE, trimming their stake 8%.

−$506.3K
16,678 sh @ $30
FATE
Sell Valamehr Bahram · Chief R&D Officer · Open-market sale · filed Mar 15, 2022 ΔOwn −1.6%

Valamehr Bahram sold $97.1K of FATE, trimming their stake 2%.

−$97.1K
3,067 sh @ $32
FATE
Sell Valamehr Bahram · Chief R&D Officer · Open-market sale · filed Mar 15, 2022 ΔOwn −1.2%

Valamehr Bahram sold $71.3K of FATE, trimming their stake 1%.

−$71.3K
2,195 sh @ $32
FATE
Sell Valamehr Bahram · Chief R&D Officer · Open-market sale · filed Mar 15, 2022 ΔOwn −1.6%

Valamehr Bahram sold $98.6K of FATE, trimming their stake 2%.

−$98.6K
2,960 sh @ $33
FATE
Sell Valamehr Bahram · Chief R&D Officer · Open-market sale · filed Mar 15, 2022 ΔOwn −0.1%

Valamehr Bahram sold $3.4K of FATE.

−$3.4K
100 sh @ $34
FATE
Sell Valamehr Bahram · Chief R&D Officer · Open-market sale · filed Jan 13, 2022 ΔOwn −2.7%

Valamehr Bahram sold $201.1K of FATE, trimming their stake 3%.

−$201.1K
4,152 sh @ $48
FATE
Sell Valamehr Bahram · Chief R&D Officer · Open-market sale · filed Jan 13, 2022 ΔOwn −0.3%

Valamehr Bahram sold $20.5K of FATE.

−$20.5K
418 sh @ $49
FATE
Sell Valamehr Bahram · Chief R&D Officer · Open-market sale · filed Jan 12, 2022 ΔOwn −3.3%

Valamehr Bahram sold $243K of FATE, trimming their stake 3%.

−$243K
5,245 sh @ $46
FATE
Sell Valamehr Bahram · Chief R&D Officer · Open-market sale · filed Jan 12, 2022 ΔOwn −0.2%

Valamehr Bahram sold $16.6K of FATE.

−$16.6K
351 sh @ $47
Advertisement

About FATE insider activity

This page tracks every recent Form 4 filed for FATE THERAPEUTICS INC with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is FATE insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for FATE THERAPEUTICS INC usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.